Tags Posts tagged with "MSTX"

MSTX

Mast Therapeutics MSTX Stock News

0 2753
Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics is having an overwhelmingly strong day in the market today. When the opening bell rang, the stock was...
Mast Therapeutics MSTX Stock News

0 3893
Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics is having a relatively strong day in the market today. Since the opening bell, the stock has been...
Mast Therapeutics MSTX Stock News

0 3478
Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics is having an incredibly strong start to the trading week today. As soon as the opening bell rang,...
Mast Therapeutics MSTX Stock News

0 2574
Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics has had a rough time in the market as of late. After announcing recently that a Phase 3...
Mast Therapeutics MSTX Stock News

0 4904
Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics has had an incredibly rough week in the market this week, and for good reason. The company's Phase...
Mast Therapeutics MSTX Stock News

0 4732
Update 9/20/2016 2:12 Primary Endpoint Missed A press release was just offered showing that MSTX missed its primary endpoint in the clinical study discussed in...
Mast Therapeutics MSTX Stock News

0 3764
Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics has been on quite the rollercoaster ride as of late. Over the past couple of weeks, we saw...
Mast Therapeutics MSTX Stock News

0 1876
Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics had an...
Mast Therapeutics MSTX Stock News

0 4334
Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics has been an incredible stock to follow as of late, and for good reason. The stock has gained...
Mast Therapeutics MSTX Stock News

0 3341
Mast Therapeutics Inc (NYSE: MSTX) Mast Therapeutics is having an incredible day in the market today. A Roth Capital analyst weighed in on the stock...

Thought Leader Discussions

Josh Disbrow head shot1 (1)

0 1412
Aytu Bioscience Inc (OTCMKTS: AYTU) Recently, the CNA Finance team had an opportunity to speak with Josh Disbrow, CEO of Aytu Bioscience. Josh Disbrow has...